Botulinum Toxin Injection
Pronunciation: bot-yoo-LY-num TOK-sin
A physiatric procedure in which botulinum toxin is injected into overactive muscles to reduce pathological tone, manage pain, or treat focal dystonia.
Full Definition
Botulinum toxin injections are a cornerstone intervention in PM&R for managing focal spasticity, dystonia, and musculoskeletal pain. The toxin temporarily blocks acetylcholine release at the neuromuscular junction, reducing involuntary muscle overactivity for three to six months. In editorial contexts, the procedure is documented in physiatric procedure notes, prior-authorization requests, and follow-up evaluations. Brand names (Botox, Dysport, Xeomin, Myobloc) are often used in clinical records; editors should ensure consistency and generic/brand distinction where required by style guides. The term should not be abbreviated to 'Botox' in formal clinical documents.
Usage
Usage note: Use the generic term 'botulinum toxin' in formal documents; brand names may appear in parentheses where clinically relevant. Do not use 'Botox' as a generic term.
In Context
- "Botulinum toxin injection was administered to the left biceps brachii and wrist flexors to address upper-limb spasticity following stroke." — Physiatric procedure note
- "Prior authorization for botulinum toxin injection was submitted with documentation of failed conservative management." — Insurance prior-authorization request